SEARCH

SEARCH BY CITATION

References

  • 1
    Schwarz, S. and Leweling, H., Multiple sclerosis and nutrition. Mult. Scler. 2005. 11: 2432.
  • 2
    Swank, R. L. and Dugan, B. B., Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990. 336: 3739.
  • 3
    Gold, R., Linington, C. and Lassmann, H., Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006. 129: 19531971.
  • 4
    Hedstrom, A. K., Olsson, T. and Alfredsson, L., High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult. Scler. 2012. 18: 13341336.
  • 5
    Munger, K. L., Chitnis, T. and Ascherio, A., Body size and risk of MS in two cohorts of US women. Neurology 2009. 73: 15431550.
  • 6
    Shoelson, S. E., Herrero, L. and Naaz, A., Obesity, inflammation, and insulin resistance. Gastroenterology 2007. 132: 21692180.
  • 7
    Fantuzzi, G., Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005. 115: 911919.
  • 8
    Piccio, L., Stark, J. L. and Cross, A. H., Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J. Leukoc. Biol. 2008. 84: 940948.
  • 9
    Fruebis, J., Tsao, T. S., Javorschi, S., Ebbets-Reed, D., Erickson, M. R., Yen, F. T., Bihain, B. E. et al., Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA 2001. 98: 20052010.
  • 10
    Kadowaki, T. and Yamauchi, T., Adiponectin and adiponectin receptors. Endocr. Rev. 2005. 26: 439451.
  • 11
    Tilg, H. and Moschen, A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 2006. 6: 772783.
  • 12
    Musabak, U., Demirkaya, S., Genc, G., Ilikci, R. S. and Odabasi, Z., Serum adiponectin, TNF-alpha, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens. Neuroimmunomodulation 2011. 18: 5766.
  • 13
    Hietaharju, A., Kuusisto, H., Nieminen, R., Vuolteenaho, K., Elovaara, I. and Moilanen, E., Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study. Eur. J. Neurol. 2010. 17: 332334.
  • 14
    O'Connor, R. A. and Anderton, S. M., Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol. 2008. 193: 111.
  • 15
    Ma, K., Cabrero, A., Saha, P. K., Kojima, H., Li, L., Chang, B. H., Paul, A. et al., Increased beta oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J. Biol. Chem. 2002. 277: 3465834661.
  • 16
    Nishida, M., Funahashi, T. and Shimomura, I., Pathophysiological significance of adiponectin. Med. Mol. Morphol. 2007. 40: 5567.
  • 17
    Ouedraogo, R., Gong, Y., Berzins, B., Wu, X., Mahadev, K., Hough, K., Chan, L. et al., Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J. Clin. Invest. 2007. 117: 17181726.
  • 18
    Brochu-Gaudreau, K., Rehfeldt, C., Blouin, R., Bordignon, V., Murphy, B. D. and Palin, M. F., Adiponectin action from head to toe. Endocrine 2010. 37: 1132.
  • 19
    Wan, Y. Y. and Flavell, R. A., Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 2005. 102: 51265131.
  • 20
    Wilk, S., Scheibenbogen, C., Bauer, S., Jenke, A., Rother, M., Guerreiro, M., Kudernatsch, R. et al., Adiponectin is a negative regulator of antigen-activated T cells. Eur. J. Immunol. 2011. 41: 23232332.
  • 21
    Fantuzzi, G., Adiponectin and inflammation: consensus and controversy. J. Allergy Clin. Immunol. 2008. 121: 326330.
  • 22
    Tsang, J. Y., Li, D., Ho, D., Peng, J., Xu, A., Lamb, J., Chen, Y. et al., Novel immunomodulatory effects of adiponectin on dendritic cell functions. Int. Immunopharmacol. 2011. 11: 604609.
  • 23
    Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J. et al., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 2009. 15: 930939.
  • 24
    Kraszula, L., Jasinska, A., Eusebio, M. O., Kuna, P., Glabinski, A. and Pietruczuk, M., Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis. Neurol. Neurochir. Pol. 2012. 46: 2228.
  • 25
    Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E. et al., Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 2011. 17: 5563.
  • 26
    Mao, X., Kikani, C. K., Riojas, R. A., Langlais, P., Wang, L., Ramos, F. J., Fang, Q. et al., APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell Biol. 2006. 8: 516523.
  • 27
    Hug, C., Wang, J., Ahmad, N. S., Bogan, J. S., Tsao, T. S. and Lodish, H. F., T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl. Acad. Sci. USA 2004. 101: 1030810313.
  • 28
    Takemura, Y., Ouchi, N., Shibata, R., Aprahamian, T., Kirber, M. T., Summer, R. S., Kihara, S. et al., Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J. Clin. Invest. 2007. 117: 375386.
  • 29
    Okamoto, Y., Arita, Y., Nishida, M., Muraguchi, M., Ouchi, N., Takahashi, M., Igura, T. et al., An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm. Metab. Res. 2000. 32: 4750.
  • 30
    Yamauchi, T., Kamon, J., Waki, H., Imai, Y., Shimozawa, N., Hioki, K., Uchida, S. et al., Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J. Biol. Chem. 2003. 278: 24612468.
  • 31
    Qi, Y., Takahashi, N., Hileman, S. M., Patel, H. R., Berg, A. H., Pajvani, U. B., Scherer, P. E. et al., Adiponectin acts in the brain to decrease body weight. Nat. Med. 2004. 10: 524529.
  • 32
    Gimenez, M. A., Sim, J., Archambault, A. S., Klein, R. S. and Russell, J. H., A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord. Am. J. Pathol. 2006. 168: 12001209.
  • 33
    Wang, C., Xin, X., Xiang, R., Ramos, F. J., Liu, M., Lee, H. J., Chen, H. et al., Yin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cells. J. Biol. Chem. 2009. 284: 3160831615.
  • 34
    Fleming, K. K., Bovaird, J. A., Mosier, M. C., Emerson, M. R., LeVine, S. M. and Marquis, J. G., Statistical analysis of data from studies on experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2005. 170: 7184.